Suppr超能文献

人血浆中的接触激活是由因子XII(哈格曼因子)的锌离子调节触发的。

Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor).

作者信息

Schousboe I

机构信息

Department of Medical Biochemistry and Genetics, Panum Institute, University of Copenhagen, Denmark.

出版信息

Blood Coagul Fibrinolysis. 1993 Oct;4(5):671-8.

PMID:7507361
Abstract

Conditions for triggering factor XII to function in the autoactivation reaction in blood coagulation in the presence of different surfaces have been studied using prekallikrein-deficient plasma. Autoactivation was recorded in a chromogenic assay by measuring the amidolytic activity of factor XIIa. The results showed that autoactivation of factor XII was achieved only after modulation of factor XII. This modulation was mediated by Zn2+ and did not require an activating surface. Following modulation, the autoactivation proceeded in the presence of a negatively charged phospholipid or sulphatide, but the sulphatide-mediated autoactivation was inhibited by Zn2+. In the presence of Zn2+ (6.6 mumol/ml plasma), the rate constant for the autoactivation following modulation was calculated to be 3.1 x 10(4) M-1 s-1 and 1.2 x 10(4) M-1 s-1 for the phospholipid and the sulphatide-mediated reactions, respectively. In the absence of Zn2+ no activation was observed in the presence of a negatively charged phospholipid. After removal of Zn2+ by EDTA, the rate constant for the sulphatide-mediated autoactivation increased to 5.7 x 10(4) M-1 s-1 in the presence and 1.0 x 10(5) M-1 s-1 in the absence of a negatively charged phospholipid (phosphatidylinositol phosphate). Dextran sulphate was not able to mediate autoactivation, in either the presence or absence of Zn2+. Aprotinin completely blocked the modulation and/or autoactivation. Soy bean trypsin inhibitor prolonged the period required for autoactivation to start, but had no effect on the autoactivation rate. The main conclusions are that Zn2+ is required to initiate contact activation, modulating factor XII for autoactivation. This modulation does not require the presence of an activating surface.

摘要

利用前激肽释放酶缺陷血浆,研究了在不同表面存在的情况下,触发因子XII在血液凝固的自动激活反应中发挥作用的条件。通过测量因子XIIa的酰胺水解活性,在显色测定中记录自动激活情况。结果表明,因子XII的自动激活仅在因子XII被调节后才能实现。这种调节由Zn2+介导,且不需要激活表面。调节后,自动激活在带负电荷的磷脂或硫脂存在的情况下进行,但硫脂介导的自动激活受到Zn2+的抑制。在存在Zn2+(6.6 μmol/ml血浆)的情况下,调节后磷脂介导和硫脂介导反应的自动激活速率常数分别计算为3.1×10⁻⁴ M⁻¹ s⁻¹和1.2×10⁻⁴ M⁻¹ s⁻¹。在不存在Zn2+的情况下,在带负电荷的磷脂存在时未观察到激活。用EDTA去除Zn2+后,在存在和不存在带负电荷的磷脂(磷脂酰肌醇磷酸)的情况下,硫脂介导的自动激活速率常数分别增加到5.7×10⁻⁴ M⁻¹ s⁻¹和1.0×10⁻⁵ M⁻¹ s⁻¹。无论是否存在Zn2+,硫酸葡聚糖都不能介导自动激活。抑肽酶完全阻断调节和/或自动激活。大豆胰蛋白酶抑制剂延长了自动激活开始所需的时间,但对自动激活速率没有影响。主要结论是,启动接触激活需要Zn2+,调节因子XII以进行自动激活。这种调节不需要激活表面的存在。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验